Farmak expands its range of drugs for treatment of acute (stroke) and chronic cerebrovascular disorders – Lira (citicoline). The Company's experts have developed and launched Lira as 30 ml syrup.
Farmak is actively working towards the treatment of cardiovascular and cerebrovascular diseases. In particular, it focuses on ensuring full-scale provision of proper quality and affordable treatment of acute and chronic cerebral circulation disorders in adults, and neurological diseases in children. To that end, the Company's experts have developed and launched the medicinal product Lira as 30 ml syrup.
The medicinal product is prescribed to adult patients in the acuity period and on the following states:
Lira Syrup can also be used to treat muscle hypertonia of the lower extremities in children, encephalopathy, infantile cerebral paralysis (ICP), traumatic brain injury, effects of neuroinfections, and ischemic conditions during prenatal development.
The course of treatment is at least 45 days.
Vlast Deneg [The Power of Money] magazine has published the rating of TOP 25 successful marketing campaigns held in the Ukrainian market in 2020 – the first half of 2021. The rating includes marketing projects implemented by both domestic companies and Ukrainian representative offices of foreign companies. The leaders include: Farmak, Carlsberg Ukraine, Avon...
Each city or town has its own traditions. We follow the old and develop the new ones ourselves. It has become a good tradition for Farmak to congratulate Shostka on its Town Day in a sporty way. The anniversary race “Farmak: Run for Your Health” has been held by the Company for the fifth time. […]
The 5th anniversary race organized by Farmak on the occasion of Shostka Town Day will be held with the support of the local authorities in an offline format under the motto “Run a race and take care of your health!” The race will take place on September 3 in Shostka as part of the celebration of […]